Correlation Between BeiGene and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both BeiGene and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and AN2 Therapeutics, you can compare the effects of market volatilities on BeiGene and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and AN2 Therapeutics.
Diversification Opportunities for BeiGene and AN2 Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BeiGene and AN2 is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of BeiGene i.e., BeiGene and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between BeiGene and AN2 Therapeutics
Given the investment horizon of 90 days BeiGene is expected to generate 37.0 times less return on investment than AN2 Therapeutics. But when comparing it to its historical volatility, BeiGene is 2.32 times less risky than AN2 Therapeutics. It trades about 0.01 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 109.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would earn a total of 28.00 from holding AN2 Therapeutics or generate 25.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BeiGene vs. AN2 Therapeutics
Performance |
| Timeline |
| BeiGene |
| AN2 Therapeutics |
BeiGene and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BeiGene and AN2 Therapeutics
The main advantage of trading using opposite BeiGene and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| BeiGene vs. Ascendis Pharma AS | BeiGene vs. Apellis Pharmaceuticals | BeiGene vs. Akero Therapeutics | BeiGene vs. Blueprint Medicines Corp |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |